119 related articles for article (PubMed ID: 21108519)
1. Study Results Support Telaprevir-Based Therapy for HCV.
AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
[No Abstract] [Full Text] [Related]
2. Phase 3 study results released for telaprevir and HCV.
AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535
[No Abstract] [Full Text] [Related]
3. [Studies with telaprevir].
MMW Fortschr Med; 2011 Jul; 153(29-31):15. PubMed ID: 21830727
[No Abstract] [Full Text] [Related]
4. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
5. Telaprevir for chronic HCV infection.
van der Meer AJ; de Knegt RJ
N Engl J Med; 2009 Jul; 361(5):533-4; author reply 534-5. PubMed ID: 19641215
[No Abstract] [Full Text] [Related]
6. The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.
Gentile I; Carleo MA; Borgia F; Castaldo G; Borgia G
Expert Opin Investig Drugs; 2010 Jan; 19(1):151-9. PubMed ID: 20001560
[TBL] [Abstract][Full Text] [Related]
7. Telaprevir: hope on the horizon, getting closer.
Weisberg IS; Jacobson IM
Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Gellad ZF; Reed SD; Muir AJ
Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
[TBL] [Abstract][Full Text] [Related]
9. [Telaprevir: new possibilities for antiviral treatment in patients with chronic hepatitis C].
Nikitin IG; Gogova LM; Baikova IE; Kislyakov VA; Volynkina VM
Ter Arkh; 2012; 84(11):75-80. PubMed ID: 23252254
[TBL] [Abstract][Full Text] [Related]
10. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
11. [Therapy of hepatitis C: new inhibitors as hammers against HCV].
Bublak R
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643
[No Abstract] [Full Text] [Related]
12. Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C.
O'Brien C
J Viral Hepat; 2006 May; 13 Suppl 1():6-14. PubMed ID: 16630042
[TBL] [Abstract][Full Text] [Related]
13. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
Fernández-Yunquera A; Rincón D; Salcedo M; Bañares R
Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883
[No Abstract] [Full Text] [Related]
14. Telaprevir: a new hope in the treatment of chronic hepatitis C?
Fowell AJ; Nash KL
Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
[TBL] [Abstract][Full Text] [Related]
15. [New times for the treatment of chronic hepatitis C].
Gerstoft J; Fomsgaard A
Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
[No Abstract] [Full Text] [Related]
16. New HCV drugs trigger race for more tolerable therapies.
Williams SC
Nat Med; 2011 Dec; 17(12):1526. PubMed ID: 22146431
[No Abstract] [Full Text] [Related]
17. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
Lange CM; Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
[No Abstract] [Full Text] [Related]
18. Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy.
Lange CM; Sarrazin C; Zeuzem S
Aliment Pharmacol Ther; 2010 Jul; 32(1):14-28. PubMed ID: 20374226
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial investigates two experimental HCV drugs.
AIDS Patient Care STDS; 2010 Apr; 24(4):270. PubMed ID: 20402017
[No Abstract] [Full Text] [Related]
20. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
Manns M
MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
